Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer
Status:
Completed
Trial end date:
2000-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of DX-8951f in treating patients who have
recurrent, metastatic, or unresectable ovarian, fallopian tube, or peritoneal cancer.